LIONHEART-HCM: BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Oct 2, 2026 - P3 | N=210 | Recruiting | Sponsor: Braveheart Bio, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
|